health.cch.comHealth | Wolters Kluwer Legal & Regulatory U.S.

Health | Wolters Kluwer Legal & Regulatory U.S. Health | Wolters Kluwer Legal & Regulatory U.S. Health & the Law, Analysis and Information Home Products Resources Free Health Law Daily Trial Cheetah Log-In Kusserow on Compliance eStore About Latest Posts Kusserow on Compliance: OIG plans 2021 evaluation of nursing home discharge requirements December 21, 2020 By Richard Kusserow The HHS Office of Inspector General (OIG) announced it is planning in 2021 to examine the extent to which nursing homes meet CMS requirements for facility-initiated discharges. In its announcement, the OIG noted that a facility-initiated transfer or … [Read More...] Kusserow on Compliance: Don’t forget the conflicts of interest compliance risk area December 14, 2020 By Richard Kusserow All Compliance Programs should consider Conflicts of Interest (COI) as a major compliance high-risk area that warrants close ongoing monitoring and auditing for compliance. Regulatory compliance requires that healthcare organizations secure annual … [Read More...] Kusserow on Compliance: The OIG announces plan to begin auditing the Two-Midnight Rule December 7, 2020 By Richard Kusserow The HHS Office of Inspector General (OIG) announced that it will begin auditing short stay claims again, and when appropriate, recommend overpayment collections. The agency’s previous audits identified millions of dollars in overpayments for … [Read More...] Recently on Law & Health Kusserow on Compliance: OIG plans 2021 evaluation of nursing home discharge requirements Kusserow on Compliance: Don’t forget the conflicts of interest compliance risk area Kusserow on Compliance: The OIG announces plan to begin auditing the Two-Midnight Rule Kusserow on Compliance: OIG cautions pharmaceutical and medical device companies over speaker programs Kusserow on Compliance: A reminder about email compliance Kusserow on Compliance: Time for Compliance Program evaluation Kusserow on Compliance: DOJ announced largest health care fraud case in its history Kusserow on Compliance: DOJ compliance program guidelines once again focus on sufficiency of compliance resources Kusserow on Compliance: Compliance investigation witness interview questions Kusserow on Compliance: Inova Health System another victim of ransomware attack Cheetah Law & Health on LinkedIn Connect Twitter- @WK_HealthLaw LinkedIn- Health Law Categories Categories Select Category Accountable Care Organization Anti-Kickback Biotech Cases SCOTUS CDC Claims Appeals Congressional Budget Office Cybersecurity Department of Justice Electronic Health Records Federal Trade Commission Fraud & Abuse Genetics Government Accountability Office Government Document Health Care Compliance Health care spending HHS Centers for Medicare and Medicaid Medicaid CHIPRA Medicare Conditions of Participation coverage Part A Part B Part C Part D Food & Drug Administration Cosmetics Devices Drugs Food Food Safety Modernization Act Labeling Tobacco User Fee Program National Institutes of Health Institute of Medicine Legislation Managed Care Medical Coding Medical Loss Ratio Mental Health Military Health News Office of Inspector General Patents Patient Protection & Affordable Care Act Contraception Mandate Health Insurance Exchange Individual Mandate Medicaid Expansion Preventive Care Mandate Severability Privacy Prospective Payment Systems IPPS Two Midnight Rule OPPS Quality Reporting Skilled Nursing Social Media State Level Highlight Uncategorized Uninsured Wolters Kluwer Law & Business Contributor’s Corner Health Law Daily Legal Scholar Mid-Week Round Up Webinars Weekly Round Up White Paper Wolters Kluwer- KC Kusserow Enforcement News Ambulance Civil Money Penalties (Enforcement) Community Mental Health Centers DME Enforcement Action False Claims Home Health Kickbacks Pharmacies/Prescription Drugs Physician Arrangements Settlements Features ALJ Backlog Exclusions Database GSA Debarment List Tuomey WellCare Government Documents Kusserow on Compliance Claims Appeals Compliance Officers Corporate Integrity Agreements General Hotlines Interviews Investigations Outsourcing Oversight Policies and Procedures Risks Sanction Screening Kusserow’s Top Tips Blogroll ACA Review Beyond Health Care Reform C&M Health Law Congressional Budget Office Blog Eye on the FDA FDA Law Blog Health Affairs Blog Health Industry Washington Watch Health IT Buzz Health Law & Policy Matters Health Law Rx Health Watch Healthcare Law Insights HealthCare.gov Blog The CMS Blog The Health Care Blog The Incidental Economist The Medicare Blog The Upshot Triage Health Law Wolters Kluwer Daily Reporting Suite MediRegs Blog Medicare Blog FDA Press Releases FDA Takes Action For Failure to Submit Required Clinical Trial Results Information to ClinicalTrials.Gov April 28, 2021 Coronavirus (COVID-19) Update: April 27, 2021 April 27, 2021 FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following Thorough Safety Review April 23, 2021 Coronavirus (COVID-19) Update: April 23, 2021 April 23, 2021 CMS Blog ©2005-2018 CCH Incorporated or its affiliates| Affiliate Program | Contact Us | Permissions, Reprints & Licensing | Privacy Statement | Wolters...